Roxanne Payne
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Cancer survivorship and care
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Cancer survivorship and care 2
- CAR-T cell therapy research 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Walter J. Urba (4 shared papers)Brendan D. Curti (4 shared papers)Steven K. Seung (2 shared papers)Marka R. Crittenden (2 shared papers)David E. Sprott (1 shared paper)Steven A. Rosenberg (1 shared paper)Huayu Huang (1 shared paper)Bernard A. Fox (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Journal of Clinical Oncology (1 paper)Science Translational Medicine (1 paper)Cancer Research (1 paper)Cancer (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Roxanne Payne
8 papers receiving 766 citations
Roxanne Payne's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 551
- Immunology 314
- Cancer Research 66
- Pulmonary and Respiratory Medicine 107
- Radiology, Nuclear Medicine and Imaging 68
Countries citing papers authored by Roxanne Payne
This map shows the geographic impact of Roxanne Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne Payne more than expected).
Fields of papers citing papers by Roxanne Payne
This network shows the impact of papers produced by Roxanne Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne Payne. The network helps show where Roxanne Payne may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxanne Payne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer Hit paper breakdown → | 2022 | 339 |
| 2 | 2012 | 249 | |
| 3 | 2014 | 80 | |
| 4 | 2013 | 51 | |
| 5 | 2020 | 37 | |
| 6 | Advances in the management of cancer pain. | 1984 | 22 |
| 7 | 2013 | 2 | |
| 8 | 2024 | 1 |
About Roxanne Payne
Roxanne Payne is a scholar working on Oncology, Immunology, Molecular Biology, Anesthesiology and Pain Medicine and Public Health, Environmental and Occupational Health, having authored 8 papers that have together received 781 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer survivorship and care (2 papers), Cell Adhesion Molecules Research (1 paper), Ubiquitin and proteasome pathways (1 paper), Palliative Care and End-of-Life Issues (1 paper), Pain Management and Opioid Use (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (551 citations), Immunology (314 citations), Cancer Research (66 citations), Pulmonary and Respiratory Medicine (107 citations) and Radiology, Nuclear Medicine and Imaging (68 citations). Roxanne Payne has collaborated with scholars based in United States and India. Frequent co-authors include Walter J. Urba, Brendan D. Curti, Steven K. Seung, Marka R. Crittenden, David E. Sprott, Steven A. Rosenberg, Huayu Huang, Bernard A. Fox, Amy Leung and Rom S. Leidner. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Science Translational Medicine, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.